Cookie Policy
We value the protection of our users' privacy and our cookie usage policy. Our website uses cookies and other similar technologies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and helps us to improve the quality of our service. For more information, please click and see our Cookie Policy.

Shining at CACLP! Zybio Leads Innovation and Explores the Future of Precision Medicine

March 24, 2025 Zybio News

The 25th CACLP concluded successfully, where Zybio showcased its Innovation-Driven, Precision Empowered solution through the debut of groundbreaking products, in-depth academic sharing, and a comprehensive product matrix display, presenting a grand feast of wisdom and technology for the industry!

Game-Changing Product Debut! A New Era in Blood Cell Analysis with EXZ8000Pro

The first day of the exhibition witnessed the debut of EXZ8000Pro fully automated blood analyzer. Featuring fluorescence cascade technology and intelligent algorithms, it redefines blood cell testing with "high precision + high efficiency + full automation." The Product Manager of Hematology introduced: "From cell morphology recognition to rare abnormality screening, the EXZ8000 series makes precision diagnosis within reach!"

Academic Frontiers in Focus! Three Reports Ignite a Storm of Ideas

1、Strategic Innovation × Technological Breakthroughs

Dr. Weijing Yi from the R&D Center delivered the speech "Enhancing and Advancing Domestic IVD Quality," decoding the core drivers Chinese brand devices from three dimensions: raw material processes, quality control systems, and AI-assisted diagnostics. 

2、New Rapid Testing Solutions for Respiratory Tract

R&D team led by RD269 from Zybio’s Precision Medicine Research Institute presented the report "Highly Sensitive, Rapid, Convenient Testing: Zybio Respiratory Detection Solution." Based on advanced technologies with extraction-free processing, ultra-fast amplification in 20 minutes and dual contamination prevention, they offer instant testing solutions for diseases caused by influenza A, influenza B, and respiratory syncytial virus, etc.

3、Zybio’s Core Advantages

Zybio shared its core product advantages, R&D journey, and global strategy on site, demonstrating its dedication to the in laboratory testing and confidence in navigating industry cycles.

Comprehensive Product Matrix! Unlocking Precision Testing Scenarios in One Stop

At the exhibition, Zybio established five experiential zones: Biochemistry & Immunology, Mass Spectrometry and Microbiology Solution, Hematology & Urinalysis & Coagulation, Molecular Solution, and Zybio Cloud Intelligent Products. Each flagship was designed to address clinical pain points:

High-Speed Biochemistry-Immunology Integrated System – Delivering extreme efficiency with 800 tests/hour.

Mass Spectrometry and Microbial Identification – Pinpointing pathogens in seconds.

Hematology, Urinalysis, Coagulation – A New Era in Blood Testing

Fully Automated Molecular Detection Platforms – Comprehensive, precise nucleic acid testing solutions

Lean Regional Testing Centers – The new engine for the construction of medical consortia.

In the Name of Innovation, Reaching for the Stars

Zybio remains committed to its mission of "Accurate Diagnosis, Healthier lifestyles." CACLP this year was not only a showcase of technological strength but also a promise to collaborate with the industry for advancement. In the future, we will continue to delve deeper into the IVD field, illuminating global healthcare with innovations made in China!